Cargando…

The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells

Previous RNA immunoprecipitation followed by proteomic approaches successfully demonstrated that Embryonic Lethal, Abnormal Vision, Drosophila-Like 1 (ELAVL1) interacts with hepatitis B virus (HBV)-derived RNAs. Although ELAVL family proteins stabilize AU-rich element (ARE)-containing mRNAs, their r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanzaki, Hiroaki, Chiba, Tetsuhiro, Kaneko, Tatsuya, Ao, Junjie, Kan, Motoyasu, Muroyama, Ryosuke, Nakamoto, Shingo, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Zen, Yoh, Kotani, Ai, Sekiba, Kazuma, Otsuka, Motoyuki, Ohtsuka, Masayuki, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316910/ https://www.ncbi.nlm.nih.gov/pubmed/35887229 http://dx.doi.org/10.3390/ijms23147878

Ejemplares similares

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Kusakabe, Yuko, et al.
Publicado: (2021)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma
por: Kojima, Ryuta, et al.
Publicado: (2023)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022)

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
por: Ma, Yaojia, et al.
Publicado: (2022)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry
por: Miyakawa, Yu, et al.
Publicado: (2021)

Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
por: Haga, Yuki, et al.
Publicado: (2017)

Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
por: Maruyama, Hitoshi, et al.
Publicado: (2020)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding
por: Sekiba, Kazuma, et al.
Publicado: (2020)

Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA
por: Ohno, Motoko, et al.
Publicado: (2014)

Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine
por: Kamezaki, Hidehiro, et al.
Publicado: (2013)

Cabozantinib inhibits HBV-RNA transcription by decreasing STAT3 binding to the enhancer region of cccDNA
por: Funato, Kazuyoshi, et al.
Publicado: (2023)

Data on isoaspartylation of neuronal ELAVL proteins
por: Pulido, Mario A., et al.
Publicado: (2016)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

Inflammation and de-differentiation in pancreatic carcinogenesis
por: Seimiya, Takahiro, et al.
Publicado: (2018)

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients
por: Kondo, Takayuki, et al.
Publicado: (2023)

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2023)

Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2020)

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
por: Maruyama, Hitoshi, et al.
Publicado: (2018)

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
por: Kondo, Takayuki, et al.
Publicado: (2023)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels
por: Sekiba, Kazuma, et al.
Publicado: (2018)

ISGF3 with reduced phosphorylation is associated with constitutive expression of interferon-induced genes in aging cells
por: Yamagami, Mari, et al.
Publicado: (2018)

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction
por: Sekiba, Kazuma, et al.
Publicado: (2018)

The Characteristic Changes in Hepatitis B Virus X Region for Hepatocellular Carcinoma: A Comprehensive Analysis Based on Global Data
por: Li, Wenwen, et al.
Publicado: (2015)

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy
por: Nakamoto, Shingo, et al.
Publicado: (2017)

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Elavl3 is essential for the maintenance of Purkinje neuron axons
por: Ogawa, Yuki, et al.
Publicado: (2018)

The molecular genetics of nELAVL in brain development and disease
por: Mulligan, Meghan R., et al.
Publicado: (2023)

Hepatitis A Virus Infection and Molecular Research
por: Kanda, Tatsuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_shkdl9f0jsthvu7ede8nr0qp03